Iran Fears and a Surging Yen Send Dow Futures Down 500 Points on September 8, 2026

On September 8, 2026, Dow Jones Industrial Average futures fell by roughly 500 points as crude oil's climb toward $100 a barrel, driven by Iran's threats against Gulf energy infrastructure, rattled Wall Street ahead of the cash open. Oil never actually reached the $100 level - an explainer piece on the wire noted it stayed well short of that mark even as fears of a prolonged Middle East conflict pushed prices higher - but the scale of the move, combined with rising bets on further Federal Reserve interest-rate increases, was enough to knock hundreds of points off equity futures. The bigger structural story was the yen. Two pieces of Japanese data released in the session - a revision of second-quarter GDP up to an annualized 1.4% expansion, and July real wages that rose 2.4% year-on-year, the fastest pace since 2021 - strengthened the case for the Bank of Japan to raise interest rates. Traders responded by pushing the yen first to a six-month high against the dollar and then, later in the session, to a seven-month high. A stronger yen makes the long-running "yen carry trade" - in which investors borrow cheap yen to fund purchases of higher-yielding assets elsewhere - more expensive to hold, because any gain in the yen erodes the return on whatever was bought with it. As that trade was unwound, investors sold the assets it had funded and bought back yen, layering a second wave of pressure onto the oil-driven selloff. The dollar, weakened by the same yen strength, was left subdued heading into the next U.S. inflation report, and gold rose as an alternative to the softer dollar. A third driver was company-specific rather than macro. Novartis reported that a cholesterol drug had failed in trials, and the disappointment triggered a sector-wide selloff across biopharma stocks as investors marked down the odds of similar late-stage failures elsewhere in the industry's pipelines. GE Aerospace agreed to buy castings maker CPP for nearly $12 billion, consolidating part of the aerospace supply chain. SCREEN Holdings, the Japanese semiconductor equipment maker, moved against the weak-quarter script by raising its full-year guidance despite reporting soft first-quarter results, betting the chip-equipment cycle improves later in its fiscal year. Super Micro and Hewlett Packard Enterprise both rallied on margin beats, though analysts questioned whether the gains were already priced in given how far the shares had run this year. China added a fourth thread: August exports surged 25% and the trade surplus widened further, data released ahead of an anticipated meeting between President Trump and President Xi. The scale of the export beat fed global shipping and trade-volume plays even as it complicated the diplomatic backdrop for that meeting. None of the session's big questions were settled by the close. Whether oil pushes through $100 depends on whether Iran follows through on its threats to Gulf energy infrastructure. Whether the yen's rally extends, and the carry-trade unwind deepens, depends on the Bank of Japan's next policy move and on the U.S. inflation print the dollar was already bracing for. And whether the Trump-Xi meeting eases or hardens trade tensions will shape how markets read China's export strength going forward. The day's currents showed up cleanly in the Buy List 2026 model portfolio, which had €110,000 invested and stood at €115,569 - a total return of +5.06%, of which +4.58% came from price moves alone. Maersk (MAERSK-B.CO), the shipping group and the portfolio's best-performing position at +29.61%, is a direct beneficiary of the kind of trade-volume growth implied by China's 25% export surge. On the other side of the yen story, the portfolio's Japanese exporter holdings showed the currency drag directly: Toyota (TM) sat almost flat at +0.01% and Hitachi (6501.T) was down 5.74%, both consistent with a stronger yen cutting into the value of overseas earnings once converted back home. Novo Nordisk (NOVO-B.CO), the portfolio's other pharmaceutical holding, was down 3.97% - a smaller decline than the sector-wide, Novartis-driven selloff might have suggested, but a decline nonetheless. Vonovia (VNA.DE), the German residential landlord, remained the portfolio's largest laggard at -22.05%, a reminder that not every position in the book was moved by the day's oil-and-yen story.